SETTING: Multidrug-resistant tuberculosis (MDR-TB) has emerged as a significant public health threat in South Africa. OBJECTIVE: To describe treatment outcomes and determine risk factors associated with unfavorable outcomes among MDR-TB patients admitted to the provincial TB referral hospital in KwaZulu-Natal Province, South Africa. DESIGN: Retrospective observational study of MDR-TB patients admitted from 2000 to 2003. RESULTS: Of 1209 MDR-TB patients with documented treatment outcomes, 491 (41%) were cured, 35 (3%) completed treatment, 208 (17%) failed treatment, 223 (18%) died and 252 (21%) defaulted. Of the total number of patients with known human immunodeficiency virus (HIV) status, 52% were HIV-infected. Treatment failure, death and ...
High mortality rates have been reported for patients co-infected with extensively drug-resistant tub...
SummaryBackgroundData from Kwazulu Natal, South Africa, suggest that almost all patients with extens...
BACKGROUND: Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
Background: According to the World Health Organization, South Africa ranks as one of the highest bur...
BackgroundMultidrug resistant-tuberculosis (MDR-TB) is a threat to global tuberculosis control which...
BackgroundMultidrug resistant-tuberculosis (MDR-TB) is a threat to global tuberculosis control which...
BACKGROUND: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat t...
BACKGROUND: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat t...
Little is known about treatment of multidrug-resistant tuberculosis (MDR-TB) in high HIV-prevalence ...
Abstract Background According to the World Health Organization, South Africa ranks as one of the hig...
SummaryBackgroundData from Kwazulu Natal, South Africa, suggest that almost all patients with extens...
Setting—In KwaZulu-Natal, South Africa, a TB and HIV endemic setting, prolonged hospitalisation for ...
Background: Little is known about treatment of multidrug-resistant tuberculosis (MDR-TB) in high HIV...
Objectives: Multidrug-resistant tuberculosis (MDR-TB), a global public health threat, is establish...
High mortality rates have been reported for patients co-infected with extensively drug-resistant tub...
SummaryBackgroundData from Kwazulu Natal, South Africa, suggest that almost all patients with extens...
BACKGROUND: Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
Background: According to the World Health Organization, South Africa ranks as one of the highest bur...
BackgroundMultidrug resistant-tuberculosis (MDR-TB) is a threat to global tuberculosis control which...
BackgroundMultidrug resistant-tuberculosis (MDR-TB) is a threat to global tuberculosis control which...
BACKGROUND: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat t...
BACKGROUND: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat t...
Little is known about treatment of multidrug-resistant tuberculosis (MDR-TB) in high HIV-prevalence ...
Abstract Background According to the World Health Organization, South Africa ranks as one of the hig...
SummaryBackgroundData from Kwazulu Natal, South Africa, suggest that almost all patients with extens...
Setting—In KwaZulu-Natal, South Africa, a TB and HIV endemic setting, prolonged hospitalisation for ...
Background: Little is known about treatment of multidrug-resistant tuberculosis (MDR-TB) in high HIV...
Objectives: Multidrug-resistant tuberculosis (MDR-TB), a global public health threat, is establish...
High mortality rates have been reported for patients co-infected with extensively drug-resistant tub...
SummaryBackgroundData from Kwazulu Natal, South Africa, suggest that almost all patients with extens...
BACKGROUND: Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR...